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ABSTRACT: F420-dependent enzymes are found in many microorgan-
isms and can catalyze a wide range of redox reactions, including those with
some substrates that are otherwise recalcitrant to enzyme-mediated
reductions. Unfortunately, the scarceness of the cofactor prevents
application of these enzymes in biocatalysis. The best F420-producing
organism, Mycobacterium smegmatis, only produces 1.4 μmol per liter of
culture. Therefore, we synthesized the unnatural cofactor FO-5′-
phosphate, coined FOP. The FO core-structure was chemically
synthesized, and an engineered riboﬂavin kinase from Corynebacterium
ammoniagenes (CaRFK) was then used to phosphorylate the 5′-hydroxyl
group. The triple F21H/F85H/A66I CaRFK mutant reached 80% of FO
conversion in 12 h. The same enzyme could produce 1 mg (2.5 μmol) of
FOP in 50 mL of reaction volume, which translates to a production of 50 μmol/L. The activity toward FOP was tested for an
enzyme of each of the three main structural classes of F420-dependent oxidoreductases. The sugar-6-phosphate dehydrogenase
from Cryptosporangium arvum (FSD-Cryar), the F420:NADPH oxidoreductase from Thermobif ida fusca (TfuFNO), and the
F420-dependent reductases from Mycobacterium hassiacum (FDR-Mha) all showed activity for FOP. Although the activity for
FOP was lower than that for F420, with slightly lower kcat and higher Km values, the catalytic eﬃciencies were only 2.0, 12.6, and
22.4 times lower for TfuFNO, FSD-Cryar, and FDR-Mha, respectively. Thus, FOP could be a serious alternative for replacing
F420 and might boost the application of F420-dependent enzymes in biocatalysis.
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■ INTRODUCTION
The naturally occurring cofactor F420 was discovered in 1972 in
methanogenic archaea where it plays a crucial role in one-
carbon catabolism.1 Nowadays, F420 is known to be present in
a wide range of archaea and bacteria in which it plays an
important role in many processes as a redox cofactor.2−5 In
several Actinobacteria, for instance, it plays a crucial role in
antibiotic synthesis,6−8 as well as aﬂatoxin degradation,5,9,10
and degradation of other aromatic compounds.11−13 Also, the
notorious pathogen Mycobacterium tuberculosis has a high
abundance of F420-dependent proteins.
4 In this organism, F420
is crucial in the regulation of oxidative and nitrosative
stress.14−16 Ironically, a series of antitubercular nitroimidazole
prodrugs, like pretomanid (PA-824) and delamanid (OPC-
67683), are speciﬁcally activated by a F420-dependent reductase
in vivo, releasing toxic NO.17−19
Structurally, the 7,8-didemethyl-8-hydroxy-5-deazariboﬂavin
catalytic core of F420, called FO, is analogous to that of
riboﬂavin20 (see Figure 1). Its chemistry, however, resembles
more that of nicotinamide dinucleotide (NAD(P)+), as F420
can only perform two-electron hydride transfers and is hardly
reactive toward molecular oxygen. Its reduction potential of
−360 mV is lower than that of NAD(P)+ and the riboﬂavin
derived cofactors ﬂavin mononucleotide (FMN) and ﬂavin
adenine dinucleotide (FAD), which are −320 and −220 mV,
respectively.21 Apart from the FO core, the rest of the structure
is very diﬀerent than that of the nicotinamide and ﬂavin
cofactors. The ribityl tail of FO is extended with a 5′-phospho-
L-lactyl moiety, forming F420-0, and this is in turn elongated by
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Figure 1. Structure of F420 and related compounds.
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a poly-γ-glutamyl tail.20 The length of the poly-γ-glutamyl tail
depends on the organism and varies from 2 to 9 monomers.3,22
Interestingly, the larger part of the poly-γ-glutamyl tail is not
bound to the enzyme, as was seen in several crystal structures
and modeled protein structures.9,23−28 Ney et al.,3 however,
showed that electrostatic interactions of the poly-γ-glutamyl
tail with enzymes of the split β-barrel like fold ﬂavin/
deazaﬂavin oxidoreductase (FDOR) and TIM barrel fold
luciferase-like hydride transferase (LLHT) families inﬂuences
the binding aﬃnity. It seems that a longer polyglutamyl tail
results in a higher binding aﬃnity (lower Kd and Km), which
lowers the catalytic turnover (kcat), probably because of slower
cofactor exchange rates.
The uniquely low redox potential of the cofactor makes it an
interesting candidate for the use in biocatalysis.29,30 F420-
dependent enzymes can reduce various physiologically
important heterocyclic enones, unsaturated esters, and imines,
which are inert to other enzymes.5,10,31,32 Recently, it was
shown that F420-dependent reductases (FDR), part of the split
β-barrel fold FDORs, can reduce α,β-unsaturated ketones and
aldehydes in an enantio- and regioselective fashion and,
interestingly, yielding the opposite enantiomer as would be
formed by the well-studied FMN-dependent old yellow
enzyme-type reductases.33 Also F420-dependent enantioselec-
tive secondary alcohol dehydrogenases were characterized.23,34
These enzymes could also be used as cofactor recycling
systems to supply reductases with reduced F420. The well-
studied F420:NADPH oxidoreductases
26,35−39 and sugar-6-
phosphate dehydrogenases27,40−44 could also be used as
recycling systems. These enzymes form a biocatalytic toolbox
which is anticipated to expand, as many genomes are predicted
to accommodate genes for F420-dependent enzymes that have
yet to be characterized.4,29
The main bottleneck in the application of F420-dependent
enzymes thus far is the limited availability of the cofactor.
Many of the organisms that produce F420 are hard to culture or
grow relatively slowly. The best production organism,
Mycobacterium smegmatis, still only produces 1.4 μmol/L of
culture.45,46 Straightforward organic synthesis cannot be used
as an alternative option because of the complicated,
heterogeneous molecular structure of the cofactor. Especially,
the regioselectivity is very challenging as many groups in, for
instance, the ribityl moiety and the poly-γ-glutamyl tail have
similar reactivity. Heterologous biosynthesis in faster growing
hosts was, until recently, impossible because of some missing
links in the F420-biosynthesis pathway. The recent elucidation
of the complete biosynthesis pathway made heterologous
production of the cofactor in Escherichia coli actually possible
butthus farhas the same low yields as withM. smegmatis.47
Herein we describe the chemoenzymatic production of the
unnatural F420 analogue FO-5′-phosphate, which we coined
FOP. The structure of FOP is analogous to FMN, the cofactor
that is used in enzymes that share homology with the TIM
barrel fold and split β-barrel-like fold F420-depedent oxidor-
eductases and that may be the ancestors of F420-dependent
oxidoreductases.9,23,24,41 To generate this functional alternative
for F420, the FO core was synthesized, as described by Hossain
et al.48 with small modiﬁcations. FO was 5′-phosphorylated
with an engineered variant of the riboﬂavin kinase from C.
ammoniagenes. Site-directed mutagenesis was applied to the
enzyme in order for it to accommodate FO. The enzyme
activity with FOP as a coenzyme was tested for a representative
member of each structural class of F420-dependent oxidor-
eductases.29,41
■ MATERIALS AND METHODS
Reagents and chemicals were purchased from Sigma-Aldrich
(St. Louis, MO, U.S.A.) unless indicated otherwise. Mutagenic
primers were also ordered at Sigma-Aldrich. Ligase, and
restriction endonucleases were obtained from New England
Biolabs (NEB, Ipswich, MA, U.S.A.). PfuUltra Hotstart PCR
Mastermix (Agilent Technologies) was used for mutagenic
PCR (QuikChange). Plasmid DNA was isolated using the
QIAprep Miniprep Kit, and PCR products were puriﬁed with
the QIAquick PCR Puriﬁcation Kit (Qiagen, Valencia, CA,
U.S.A.).
F420 Production. F420 was isolated from Mycobacterium
smegmatis as described by Bashiri et al. and Isabelle et al.45,46
The production strain M. smegmatis mc2 4517 was a kind gift
from Dr. G. Bashiri from the University of Auckland, New
Zealand.
FO and FO-7-Methyl Synthesis. FO was synthesized
using the approach described by Hossain et al.48 with a
modiﬁcation for the reductive amination procedure. These two
steps are done in one step via reductive amination with sodium
cyanoborohydride, instead of synthesis of the mixture of
anomers and then reduction of them. FO-7-Me was
synthesized using the same modiﬁed procedure as for synthesis
of FO. Detailed procedures and physical data can be found in
the Supporting Information.
Gene Cloning and Mutagenesis of C. ammoniagenes
Riboﬂavin Kinase. The C. ammoniagenes riboﬂavin kinase
gene (CaRFK) was ordered at GenScript (Piscataway, NJ,
U.S.A.), codon optimized for E. coli. It was composed of the C-
terminal kinase domain of the FAD synthetase gene, ribF
(NCBI#: D37967.1), previously described by Iamurri et al.49
The nucleotide sequence and protein sequence are shown in
Figures S1 and S2, respectively. The gene was cloned into a
pBAD/Myc-His vector (Invitrogen, Thermo-Fisher) using
restriction sites NdeI and HindIII, following standard cloning
procedures.50 Site-directed mutagenesis was performed on the
riboﬂavin kinase gene with the use of mutagenic primers,
degenerate at a chosen codon, using the QuikChange
mutagenesis kit (Stratagene), following the procedure of the
manufacturer. Primers were designed with the Agilent
QuikChange primer design tool (http://www.genomics.
agilent.com/primerDesignProgram.jsp). The used primers are
listed in Table S1. Sequencing was performed at GATC
(Constanz, Germany). The plasmids were transformed into
calcium chloride chemically competent E. coli NEB 10-beta
(New England Biolabs Ipswich, MA, U.S.A.) for ampliﬁcation
and protein expression, using standard protocols.50
Expression and Puriﬁcation of C. ammoniagenes
Riboﬂavin Kinase. An E. coli NEB 10-beta overnight culture
in Terriﬁc broth (TB), supplemented with 50 μg mL−1
ampicillin, was grown at 37 °C, 135 rpm. The overnight
culture was diluted a hundred times in 200 mL of fresh TB
with 50 μg mL−1 ampicillin in a 500 mL Erlenmeyer ﬂask. This
was grown at 37 °C, 135 rpm until the OD600 reached ∼0.5, at
which the culture was induced with 0.2% L-arabinose and
further grown at 17 °C for 36 h. Cells were harvested by
centrifugation at 4000g for 20 min at 4 °C. The cell pellets
were stored at −20 °C until puriﬁcation. Cell pellets were
resuspended in about 10 mL of 50 mM Tris/HCl pH 8.0, 200
mM NaCl, 10 mM imidazole, 1 mM β-mercaptoethanol, and
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cOmplete mini EDTA-free Protease Inhibitor Cocktail. The
cells were lysed by sonication, using a Sonics Vibra-Cell VCX
130 sonicator with a 3 mm stepped microtip (5s on, 10s oﬀ,
70% amplitude, 7.5 min). Cell debris were pelleted by
centrifugation at 8000g for 40 min at 4 °C. The clear
supernatant was incubated on 2 mL of Ni-Sepharose High
Performance (GE Healthcare, Eindhoven, The Netherlands)
for 12 h at 4 °C, with gentle shaking. The column was washed
extensively with 3 column volumes of 50 mM Tris/HCl pH
8.0, 200 mM NaCl, 20 mM imidazole, and the protein was
eluted with 50 mM Tris/HCl pH 8.0, 200 mM NaCl, 300 mM
imidazole. The eluted protein was then desalted and
concentrated using Amicon Ultra centrifugal ﬁlter units with
a 3 kDa molecular weight cutoﬀ, exchanging the buﬀer with 50
mM Tris/HCl pH 8.0, 200 mM NaCl. The protein was ﬂash-
frozen in liquid nitrogen and stored at −80 °C until further
use. Purity was checked with SDS-PAGE analysis, and protein
concentrations were measured by Bradford analysis, using the
standard protocols.
Expression and Puriﬁcation of F420-Dependent
Enzymes. Genes, plasmids, and host strains were already in
the collection of this lab from earlier studies. T. fusca
F420:NADPH oxidoreductase (TfuFNO) was expressed and
puriﬁed as described by Kumar and Nguyen et al.26 R. jostii
RHA1 F420-dependent glucose-6-phosphate dehydrogenase
(RHA1-FGD) was expressed and puriﬁed as described by
Nguyen et al.27 The sugar-6-phosphate dehydrogenase from C.
arvum (FSD-Cryar) was expressed and puriﬁed as described by
Mascotti and Kumar et al.41 The F420-dependent reductases
from M. hassiacum (FDR-Mha) and R. jostii RHA1 (FDR-
RHA1) were expressed and puriﬁed as described by Mathew
and Trajkovic et al.33
Riboﬂavin Kinase Activity Assay and HPLC Analysis.
The activity of wild-type CaRFK and mutant enzymes toward
riboﬂavin and FO was measured in conversion experiments.
Conversion mixtures contained 1 μM enzyme and 50 μM
riboﬂavin, FO-7-methyl (FO-7-Me) or FO in 50 mM Tris/
HCl pH 8, 100 mM MgCl2, 10 mM ATP. The reaction
mixtures with a total volume of 0.5 mL were incubated at room
temperature or 37 °C for 12 h. Samples were taken either at
certain intervals (0, 5, 10, 15, 30 min) or after 12 h.
Conversions were measured by either high-performance liquid
chromatography (HPLC) or thin layer chromatography
(TLC). The TLC method was previously described by Iamurri
et al.49 The HPLC method was a modiﬁed version of that of
Iamurri et al. The reactions were quenched with 100% formic
acid (FA), 1:5 FA:sample, incubating on ice for 5 min. Then,
the samples were spun down at 8000g in a table top centrifuge
at 4 °C and neutralized with 1.6 mM NaOH, 1:9
NaOH:sample. Supernatant (100 μL) was used for HPLC
analysis. Samples were separated on an Alltech Alltime HP
C18 5 μ, 250 mm column by applying a linear gradient of 50
mM ammonium acetate pH 6.0 with 5% acetonitrile (buﬀer A)
and 100% acetonitrile (buﬀer B): t = 0 min/100:0 (A:B), t =
20 min/75:30 (A:B), t = 30 min/5:95 (A:B), t = 35 min/5:95
(A:B), t = 40 min/75:30 (A:B), t = 45 min/100:0 (A:B). The
separation was monitored in time at 262 nm. The retention
times for FO, FOP, FO-7-Me, and FO-7-Me-P are 17, 15, 21,
and 19 min, respectively.
Chemoenzymatic Synthesis of FOP. CaRFK F21H
F85H A66I (10 μM) was added to 50 μM FO in 50 mL of
50 mM Tris/HCl pH 8, 100 mM MgCl2, 10 mM ATP and was
incubated at room temperature for 24 h. The reaction mixture
was spun down at 8000g in a table top centrifuge and applied
to a Reveleris C18-WP Flash cartridge column. FOP was
eluted with deionized water, and purity was veriﬁed by HPLC,
as described above. The product was concentrated by water
evaporation under reduced pressure with a rotary evaporator.
FOP was either kept at −20 °C for long-term storage or at 4
°C for short-term storage. Obtained FOP was conﬁrmed by
HRMS (result is shown in Supporting Information).
Steady-State Activity Assays for Selected F420-
Dependent Enzymes with FO, FOP, and F420. The
Michaelis−Menten kinetic parameters for TfuFNO with FO
and FOP were obtained by the spectrophotometric assay as
described by Kumar and Nguyen et al.26 In short, the
measurements were performed at 25 °C by adding 25−50 μM
enzyme to 50 mM KPi, pH 6.0, with a constant NADPH
concentration of 250 μM and varying concentrations of FO
and FOP between 0.625 and 50 μM. The activity of RHA1-
FGD and FSD-Cryar with FO, F420 and FOP was obtained by
the spectrophotometric assay as described by Nguyen et al.27
and Mascotti and Kumar et al.,41 respectively. Glucose-6-
phosphate was used as substrate at a constant concentration of
20 mM. The concentration of FO, FOP, and F420 was varied
between 1.25 and 50 μM in the appropriate Tris/HCl-based
buﬀers for each enzyme at 25 °C.27,41
The absorbance at 400 nm was followed in time for all the
experiments, and observed slopes (kobs) were calculated with
ε400 (F420) = 25.7 mM
−1 cm−1. All experiments were performed
in triplicates. The kobs values were plotted against de FO/FOP/
F420 concentration, and the data was ﬁtted to the Michaelis−
Menten (eq 1) or Hill equation (eq 2) by nonlinear regression,
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The kinetic parameters for the F420-dependent reductase
FDR-Mha were obtained as follows: FOPH2 and F420H2 were
prepared by incubating 500 μM FOP or F420 with 10 μM FSD-
Cryar and 20 mM glucose-6-phosphate in 50 mM Tris/HCl,
pH 8.0, until the yellow color disappeared. Then, the mixture
was passed through an Amicon Ultra 0.5 mL centrifugal ﬁlter,
10 kDa molecular weight cutoﬀ. The ﬁltrate, containing 500
μM FOPH2 or F420H2, was then immediately used for a
spectrophotometric assay. The assay mixture contained 0.1−1
μM FDR-Mha, 1.0 mM 2,6,6-trimethyl-2-cyclohexene-1,4-
dione, and various concentrations of FOPH2 and F420H2
between 1.25 and 50 μM in 50 mM Tris/HCl, pH 8.0. The
increase in absorbance at 400 nm was measured in time over
several minutes. The kobs values were calculated using ε400
(F420) = 25.7 mM
−1 cm−1. All experiments were performed in
triplicates at 25 °C. Kinetic data was analyzed by nonlinear
regression and ﬁtted to the Hill equation for cooperative
binding (eq 2), using GraphPad Prism v. 6.0 (GraphPad
Software Inc., La Jolla, CA, U.S.A.).
Conversion Experiments with F420-Dependent Re-
ductases from M. hassiacum and R. jostii RHA1 with FO,
FOP, and F420. The reaction mixture contained 400 μL of 50
mM Tris/HCl pH 8.0 supplemented with 1.0 mM
cinnamaldehyde, 20 μM FO/FOP/F420, 1.0 μM TfuFNO, 10
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mM NADPH, 25 μM FDR-RHA1/FDR-Mha, and DMSO
(3% v/v). The reaction was performed in a closed 1 mL glass
vial in the dark at 25 °C and 135 rpm for 3 h. The reaction was
quenched by adding the mixture to an equal amount of
acetonitrile and then incubated on ice for 5 min. This mixture
was spun down at 8000g in a table top centrifuge at 4 °C, and
100 μL supernatant was used for analysis on HPLC. The
depletion of substrate and formation of product were analyzed
at 240 nm, using an isocratic mobile phase of 60:40
water:acetonitrile on an Alltech Alltime HP C18 5μ, 250
mm column.
■ RESULTS
Engineering of C. ammoniagenes Riboﬂavin Kinase
toward Activity on FO. The C-terminal riboﬂavin kinase
domain (CaRFK) of the FAD synthetase (RibF) from C.
ammoniagenes, previously described by Iamurri et al.49 and
Herguedas et al.,51 was chosen for the biocatalytic 5′-
phosphorylation of FO. The truncated ribF gene (NCBI#:
D37967.1), CaRFK, was ordered, codon optimized for E. coli
and was transformed into E. coli NEB 10-beta as a pBAD-
CaRFK construct, equipped with a C-terminal 6× histidine tag.
Puriﬁcation of the respective protein, CaRFK, was achieved by
table-top nickel aﬃnity chromatography, yielding about 20 mg
L−1 pure CaRFK.
Conversion experiments with 50 μL of FO and 1−50 μM
CaRFK, analyzed by reverse-phase HPLC after 12 and 48 h at
20 or 37 °C, showed that the wild-type enzyme had no
detectable activity toward FO. Therefore, structure-guided site-
directed mutagenesis was performed. The crystal structure of
the C-terminal riboﬂavin kinase domain of RibF, PDB ID
5A89,51 was used to identify suitable sites for mutagenesis.
Polar amino acids were introduced at positions 21, 85, and 122
with QuikChange-PCR to accommodate the 8-hydroxyl group
of FO (numbering according to the protein sequence given in
Figure S2). Single-point mutations, as well as double
mutations, however, did not result in any activity toward FO.
Yet, interestingly, the apparent activity toward another
deazaﬂavin, FO-7-methyl (8-demethyl-8-hydroxy-5-deazaribo-
ﬂavin, a molecule that is structurally halfway riboﬂavin and
FO), was increased by these mutations, while the activity
toward RF was signiﬁcantly diminished (see Figure 2).
Gratifyingly, introduction of three mutations resulted in
activity on FO: mutations A66 V/A66I, together with
F21H/Y and F85H/Y yielded FO conversions of 61 to 81%
in 12 h (see Figure 3). Replacing alanine at position 66 by a
valine or isoleucine might ﬁll up the void that was left vacant
by the missing 7-methyl group in FO, making it impossible for
water to reside there. Introduction of additional polar residues
at position 122 and the mutation T23S, both in the same
binding pocket facing the 8-hydroxyl group of FO, did not
increase the activity any further.
Chemoenzymatic Synthesis of FO-7-Me-P and FOP.
Incubating 50 μM FO-7-Me with 10 μM F21Y/F85H CaRFK
mutant or FO with 10 μM F21H/F85H/A66I CaRFK mutant
in a volume of 50 mL resulted in full conversion of FO-7-Me to
FO-7-Me-P and FO to FOP within 24 h at 37 °C. The product
could be puriﬁed from the other reaction components with the
aid of a preparative reverse-phase liquid chromatography and
was concentrated by rotary evaporation under reduced
pressure. The yield of 50 mL of reaction volume was about
1 mg (2.5 μmol) of FOP and FO-7-Me-P, in a ﬁnal
concentration of about 400 μM (measured by absorbance at
400 nm, ε400 = 25.7 mM
−1 cm−1). Obtained FO-7-Me-P and
FOP were conﬁrmed by HRMS (see Supporting Information).
Puriﬁcation of F420-Dependent Oxidoreductases. The
F420:NADPH oxidoreductase from T. fusca (TfuFNO) was
expressed and puriﬁed as described by Kumar and Nguyen et
al.26 with a yield of approximately 140 mg L−1 pure protein.
The glucose-6-phosphate dehydrogenase from R. jostii RHA1
(RHA1-FGD) and the sugar-6-phosphate dehydrogenase from
C. arvum (FSD-Cryar) were expressed and puriﬁed as
described by Nguyen et al.27 and Mascotti and Kumar et
al.,41 respectively. Yields of puriﬁed enzyme were similar as
described by the papers mentioned above. Similar results were
also obtained for the expression and puriﬁcation of the F420-
dependent reductases from M. hassiacum (FDR-Mha) and R.
jostii RHA1 (FDR-RHA1), as described by Mathew and
Trajkovic et al.33
Steady-State Kinetics Using FOP as Alternative
Cofactor. The activity of the F420-dependent enzymes
TfuFNO, RHA1-FGD, FSD-Cryar, and FDR-Mha toward
FO, FOP, and F420 was measured spectrophotometrically.
Steady-state kinetic parameters were measured by varying the
concentration of the coenzymes FO, FOP, and F420, while
Figure 2. Conversion of riboﬂavin and FO-7-methyl by single and
double CaRFK mutants within 12 h of incubation at 37 °C. Enzyme
concentrations are 17 μM for single mutants and 1 μM for double
mutants. Experiments were performed in duplicates. Error bars
represent standard deviations.
Figure 3. Conversion of FO to FOP within 12 h of incubation at 37
°C with several CaRFK mutants. Experiments were performed in
duplicates. Error bars represent standard deviations.
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keeping the other substrates at constant, saturating concen-
trations. The slopes of absorbance decreaseor increase in the
case of FDR-Mhaat 400 nm were measured, and the
observed rates (kobs) were calculated using ε400 = 25.7 mM
−1
cm−1. The observed rates were plotted against the cofactor
concentration and ﬁtted to the Michaelis−Menten or the Hill
model for positive cooperativity (eqs 1 and 2, respectively).
Tfu-FNO showed activity with all three tested deazaﬂavins
(FO, FOP, and F420). The kinetic data with FO and FOP did
not ﬁt well to the Michaelis−Menten kinetic model but could
be ﬁtted to a Hill plot for cooperative substrate binding
kinetics (Figures S4 and S5). This positive cooperativity can be
explained by the dimeric structure of the enzyme. Coopera-
tivity was also observed for the FNO from Archaeoglobus
fulgidus, using NADPH and FO, as reported by Le et al.52
Strangely, positive cooperativity was not seen with F420 as a
coenzyme, as discussed by Kumar and Nguyen et al.26 The
kinetic parameters for FO and FOP, however, are similar to
that of F420 (see Table 1). Thus, FO, FOP and F420 are all
equally well used as coenzymes in NADPH oxidation by
TfuFNO. The crystal structure of TfuFNO (PDB ID 5N2I),26
superimposed with the crystal structure of the F420-bound
FNO homologue from A. fulgidus (1JAY),28,39 shows that only
the FO part of F420 is bound and that the rest of the molecule
is actually located outside of the enzyme. Therefore, the
phosphate of FOP or phospho-L-lactyl and poly-γ-glutamyl tail
of F420 have only minor contributions to the binding aﬃnity.
It was found that RHA1-FGD shows no activity with FO or
FOP, while it has a kcat of 17 s
−1 and Km of 3.8 μM for F420.
27
The crystal structure of RHA1-FGD (PDB ID 5LXE),27
superimposed with the F420-bound crystal structure of the M.
tuberculosis homologue (PDB ID 3Y4B),25 shows that the ﬁrst
glutamate moiety of the F420 poly-γ-glutamyl tail forms
hydrogen bonds with the protein backbone. This could be
the reason for being unable to use FO or FOP as coenzyme,
which are lacking the glutamyl tail. FSD-Cryar, however, with
57% sequence identity to RHA1-FGD, did show detectable
activity toward FOP. The kobs data ﬁtted well to a Michaelis−
Menten curve and gave a kcat of 1.3 s
−1 and Km of 7.0 μM for
FOP (Figures S6 and S7, Table 1). Both values are lower than
the kinetic parameters measured for the native cofactor F420,
being 33 s−1 and 13.9 μM for the kcat and the Km, respectively
(Table 1). Although the Km values are in the same range
(Km,FOP is ∼2 times lower than Km,F420), the kcat value for F420 is
25 times higher than that for FOP. The catalytic eﬃciency for
FOP, however, is only 1 order of magnitude lower than that
when using F420. The measured kobs values for diﬀerent
concentrations of FO could not be ﬁtted with the formula for
the Michaelis−Menten model. A good ﬁt could be obtained
with a sigmoidal function, but the plateau was never reached
with FO concentrations up to 80 μM. Higher concentrations
could not be tested because of the solubility of FO in buﬀer.
Although the data could not be used to calculate the kinetic
parameters of FSD-Cryar with FO, it is safe to say that the Km
must be signiﬁcantly higher than that of FOP and F420. The
kobs at a concentration of 80 μM FO, the highest concentration
tested, is about 20% of the kcat with FOP (see Figure S8).
The kinetic parameters could also be established for FDR-
Mha with both FOP and F420 as coenzymes. But the kinetic
parameters for FO, however, could not be measured. The
reduced form of this deazaﬂavin could not be obtained as it
could not be reduced by FSD-Cryar or RHA1-FGD. TfuFNO,
which can reduce FO, could not be used as the necessary
excess of NADPH would interfere with the FO absorbance at
400 nm. The kobs data for both F420 and FOP ﬁtted well to a
sigmoidal Hill-curve (eq 2; Figures S9 and S10). This could
mean positive cooperativity or the fact that the lower
concentrations of the coenzymes were in the same range as
the enzyme concentration, so not being present in saturating
conditions and, thus, not ﬁtting to the Michaelis−Menten
model. The same sigmoidal behavior was also seen for the
activity of enzymes of the same structural fold class in M.
smegmatis, denoted MSMEG_3356 and MSMEG_3380, with
various concentrations of F420.
5 The asymptotes to the plateau
values of the curves still give a good description of the kcat, and
the Khalf still gives an accurate estimation for coenzyme
speciﬁcity. From Table 1, it can be seen that FOP has a
somewhat lower kcat and higher Km value than F420, but they
are still in the same range.
Conversion Experiments with FDR-Mha and FDR-
RHA1. Since the catalytic parameters could not be determined
spectrophotometrically for FDR-Mha and FO, conversion
experiments were used to compare the activity of FDR-Mha
and FDR-RHA1 with FO, FOP, and F420. The conversion of
cinnamaldehyde was measured by reverse-phase HPLC after 3
h of incubation for all three coenzymes at concentration of 20
μM. The results show that the conversion of cinnamaldehyde
is around 70% when using F420 for both FDR-Mha and FDR-
RHA1. The conversion when using FOP is close to 40%, which
is in line with the spectrophotometric experiments. The
conversion of cinnamaldehyde with FO as a coenzyme is lower
than that of FOP by about 10 to 18 percentage points. These
results show that the apparent activity follows the trend F420 >
FOP > FO (see Figure 4).
Table 1. Steady-State Kinetic Parameters with Three Diﬀerent Deazaﬂavin Cofactors
enzyme cofactor kcat (s
−1) Km or Khalf (h) (μM) kcat/Km (M









a 2.0a 1.7 × 106 2.0
FOP 3.3 4.0b (1.8) 8.3 × 105
FO 2.2 4.8b (2.9) 4.6 × 105
FSD-Cryar F420 33.0 13.6 2.4 × 106 12.6
FOP 1.3 7.0 1.9 × 105
FO - - -
FDR-Mha F420 1.8 × 10−2 12.1
b (4.4) 1.5 × 104 22.4
FOP 1.3 × 10−2 19.3b (2.9) 6.7 × 102
FO - - -
aValues described by Kumar et al.26 bKhalf values, according to eq 2, Hill coeﬃcients (h) are given in between brackets Errors are within a 10%
range.
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■ DISCUSSION
Enzymes that utilize F420 could become a biotechnological tool
of importance in the near future. The very low redox potential
of the cofactor can be utilized for the bioconversion of
compounds that would otherwise be recalcitrant to
enzymes.5,10,21,32 The now known F420-dependent reductases
and cofactor recycling systems harbor interesting activities for
biocatalysis.29,30 Genome studies revealed that many bacteria
and archaea contain putative F420-dependent enzymes that yet
have to be characterized3−5 and could potentially yield new
biocatalysts with novel interesting properties.
A bottleneck for application of F420-dependent enzymes is
the low availability of the cofactor, as many F420-producing
organisms are slow-growing and hard to culture, resulting in
low yields.45,46 Furthermore, the complex structure of the
cofactor prevents straightforward chemical synthesis methods.
The recent and remarkable eﬀorts by Bashiri et al.47 to
heterologously produce F420 in E. coli unfortunately still
resulted in similar low yields as with M. smegmatis. This
inspired us to synthesize a F420 analogue that could replace
F420.
The crystal structures of F420-dependent oxidoreductases
show that these enzymes can mainly be divided into three
distinct structural classes, namely, the Rossmann fold, TIM
barrel fold, and the split β-barrel-like fold class.27,29,41 The
same crystal structures also show that the major part of the
poly-γ-glutamyl tail of the cofactor is not bound by the
enzyme.9,23,24,26−28 The main interactions between F420 and
the enzyme are formed by the FO core structure and the
phosphate group, whereas the lactyl group and poly-γ-glutamyl
tail form less interactions. The TIM barrel fold and the split β-
barrel like fold classes share structural homology with FMN-
dependent oxidoreductases, which can explain this observed
cofactor-enzyme binding pattern. Furthermore, it was recently
shown by Mascotti and Kumar et al.41 that the TIM barrel fold
clade probably has evolved from a FMN-dependent enzyme.
Therefore, we proposed FOP, 7,8-didemethyl-8-hydroxy-5-
deazariboﬂavin-5′-phosphate, as an alternative for F420. It is
worth noting that FOP is not a naturally occurring cofactor
and is also not an intermediate in the biosynthesis of F420.
Chemical hydrolysis of F420, in order to elucidate the structure
of this cofactor by Eirich et al., however, produced FOP.20 The
authors then coined the term F+ for this deazaﬂavin
compound.
The FO core structure was synthesized by a straightforward
organic synthesis procedure. Similar to the biosynthesis of
FMN from riboﬂavin, the phosphate group was then attached
enzymatically at the 5′-position with the aid of an tailor-made
kinase. A riboﬂavin kinase (RFK) was used as starting point to
engineer a FO kinase since the catalytic core structure, FO, is
structurally very similar to that of riboﬂavin. The RFK from C.
ammoniagenes, obtained by truncation of the bifunctional FAD
synthetase, RibF, was chosen as it was already well-studied by
Iamurri et al.49 Previous research on the enzyme showed its
ease of expression and puriﬁcation and the remarkable range of
riboﬂavin analogues that could be converted, including 5-
deazariboﬂavin. Unfortunately, we discovered that RFK does
not accept FO as substrate. Therefore, structure-inspired site-
directed mutagenesis was employed to accommodate the more
hydrophilic FO in the active site. Introduction of polar residues
at position 21 and 85 could facilitate the hydroxyl-group of FO
in an otherwise hydrophobic binding pocket. Substitutions of
the phenylalanines at these positions by tyrosine and histidine
yielded the most active biocatalysts. Substitution of alanine by
valine or isoleucine at position 66 was crucial for introducing
activity toward FO, probably to ﬁll the space left vacant by the
7′-methyl group that is absent in FO. With these triple mutants
conversion of FO into FOP could be achieved. Structure-based
site-directed mutagenesis on C. ammoniagenes RFK can thus
expand the already large substrate acceptance of riboﬂavin
analogues even more, making it a useful tool for the synthesis
of unnatural (deaza)ﬂavin cofactors.
The drawback of using riboﬂavin kinase is its low stability,49
which prevents the use of cosolvents. Since the solubility of FO
and other riboﬂavin analogues in water is quite low, relatively
large reaction volumes have to be used for the production of
large amounts of phosphorylated compounds. A more stable
RFK could be a solution to this problem, if one would like to
produce FOP or other cofactors on plant scale. Still, a 50 mL
reaction resulted in the production of about 1 mg (2.5 μmol)
FOP within 24 h, which translates to a production of 50 μmol/
L. Thus, far more than the F420 yield from M. smegmatis, being
1.4 μmol/L of culture, grown over several days.
The activity of an F420-dependent oxidoreductase from each
structural class with FO, FOP, and F420 was measured. Steady-
state parameters could be determined with FOP and F420 for a
member of each class, spectrophotometrically. Experiments
with the F420:NADPH oxidoreductase from T. fusca, TfuFNO,
a member of the Rossmann fold structural class, showed that
the kinetic parameters for FO, FOP, and F420 are in the same
range. The Km values of FO and FOP are slightly higher,
resulting in a slightly lower catalytic eﬃciency that is 3.7 (FO)
or 2 (FOP) times lower than that for F420. The similarity in
kinetic parameters can be explained by the fact that only the
FO core is bound to the enzyme, as can be seen in crystal
structures.26,28
Members from the TIM barrel fold class showed a
signiﬁcant decrease in activity when FO and FOP were used
as coenzymes. The F420-dependent glucose-6-phosphate
dehydrogenase from R. jostii RHA1 shows no detectable
activity at all for the alternative deazaﬂavin cofactors. The
sugar-6-phosphate dehydrogenase from C. arvum has activity
toward FOP. Although the Km values for both FOP and F420
Figure 4. Conversion of cinnamaldehyde within 3 h of incubation at
25 °C by FDR-Mha and FDR-RHA1, using FO, FOP, and F420 as
coenzymes. Experiments were performed in duplicates. Error bars
represent standard deviations.
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are similar, the kcat for F420 is signiﬁcantly higher than that of
FOP. Still, the catalytic eﬃciency with FOP is only 1 order of
magnitude lower, meaning that the activity with FOP is
signiﬁcant and that FOP could be used as an alternative non-
natural cofactor for this enzyme. An ever lower activity was
found for FO, indicating that the phosphate moiety of the F420
cofactor is important for recognition and/or productive
coenzyme binding.
The kinetic parameters for both FDR-MHA1 and FDR-Mha,
both members of the split β-barrel fold class for F420 and FOP
revealed that the Km and kcat values are in the same order of
magnitude, although the catalytic eﬃciency is 22 times higher
for F420 than for FOP. It shows that members of this group of
F420-dependent enzymes, dedicated to perform reductions, also
can utilize the non-natural deazaﬂavin cofactor that lacks the
lactyl-poly glutamyl moiety. No steady-state kinetic parameters
could be obtained with the reduced form of FO because the
sugar-6-phosphate dehydrogenases could not be used to
prepare reduced FO. We decided to perform comparative
conversion experiments with cinnamaldehyde as substrate to
probe the eﬃciency of all three deazaﬂavin cofactors. Here we
could see that cinnamaldehyde conversion with FOP is
somewhat less eﬀective than with F420, which is in line with
the results from the spectrophotometric assay. The conversions
with FO are again lower than that with FOP but in the same
range. It shows that all three deazaﬂavins are accepted by the
tested reductases, suggesting that for catalysis only the FO part
of the F420 cofactor is essential.
The experiments have shown that F420-dependent enzymes
of all tested structural classes are active on the non-natural,
synthetic deazaﬂavin cofactor FOP and that the activity is
typically higher when compared with its precursor, FO. It
seems that in all cases, the phosphate group is important for a
higher binding aﬃnity, as seen by a lower Km, and for a higher
catalytic turnover, as seen by a higher kcat. When comparing
F420 and FOP activities the presence of a poly-γ-glutamyl tail
seems to be important for higher cofactor aﬃnities and higher
catalytic activity. Interestingly, Ney et al. discovered that the
presence of a long poly-γ-glutamyl tail of 5 to 8 glutamate
residues indeed lowered the Km, as compared with a shorter
tail of two residues, because of favorable electrostatic
interactions between tail and enzyme, but also lowered the
kcat and vice versa. The eﬀect of higher kcat with lower cofactor
aﬃnity can be explained by higher cofactor exchange rates of
enzymes at saturating conditions. Surprisingly, the same eﬀect
on kcat and Km is not seen when the poly-γ-glutamyl tail is
completely missing. Perhaps, the properties of the more
substituted phosphate diester in F420 are more favorable for
enzyme binding than that of the phosphate monoester in FOP.
The ﬁndings of this research show that FOP could also be
used as an alternative deazaﬂavin cofactor in vivo. With having
an engineered FO kinase, the introduction of a biosynthetic
route toward FOP is feasible. A great advantage of FOP over
FO is that it retains inside a cell because of the charged
phosphate group, similar to the conversion of riboﬂavin into
FMN. Also, the solubility is enhanced by the addition of a
phosphate group. Although the activity for FOP is lower than
that for F420, it is still suﬃcient enough for the use as a cofactor
in biocatalysis, as can be seen by the relatively small diﬀerences
in catalytic eﬃciency. The ease of production and higher
product yields of the cofactor could make up for the decrease
in activity when used as coenzyme in F420-dependent enzyme
reactions. Therefore, FOP could be the key to successful
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